Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
FRP Holdings
FRPH
$421M
| $156K | ﹤0.01% |
5,596
+2,420
| +76% | +$69.5K |
|
2752
Viking Therapeutics
VKTX
$4B
| $156K | ﹤0.01% |
24,729
+13,023
| +111% | +$80.5K |
|
2753
PubMatic
PUBM
$810M
| $155K | ﹤0.01% |
5,854
+1,351
| +30% | +$40.5K |
|
|
AKRO
2754
DELISTED
Akero Therapeutics
AKRO
| $153K | ﹤0.01% |
6,867
+3,088
| +82% | +$69.9K |
|
|
HCCI
2755
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $153K | ﹤0.01% |
5,279
+3,082
| +140% | +$88.2K |
|
2756
Omega Flex
OFLX
$312M
| $151K | ﹤0.01% |
1,059
+599
| +130% | +$90.8K |
|
|
BCOV
2757
DELISTED
Brightcove, Inc.
BCOV
| $151K | ﹤0.01% |
13,105
+6,633
| +102% | +$80.2K |
|
|
FMTX
2758
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $150K | ﹤0.01% |
6,517
+3,226
| +98% | +$76.3K |
|
2759
4D Molecular Therapeutics
FDMT
$562M
| $149K | ﹤0.01% |
5,505
+4,691
| +576% | +$134K |
|
|
REVG
2760
DELISTED
REV Group
REVG
| $149K | ﹤0.01% |
8,655
+5,675
| +190% | +$90.4K |
|
2761
Willdan Group
WLDN
$1.3B
| $149K | ﹤0.01% |
4,179
+2,386
| +133% | +$89.9K |
|
|
NPTN
2762
DELISTED
NEOPHOTONICS CORP
NPTN
| $149K | ﹤0.01% |
17,129
+10,036
| +141% | +$91.5K |
|
2763
Praxis Precision Medicines
PRAX
$10.1B
| $147K | ﹤0.01% |
527
+330
| +168% | +$89.5K |
|
2764
Tejon Ranch
TRC
$451M
| $147K | ﹤0.01% |
8,274
+4,164
| +101% | +$74K |
|
|
TRUE
2765
DELISTED
TrueCar
TRUE
| $147K | ﹤0.01% |
35,418
+18,515
| +110% | +$85.9K |
|
2766
Bar Harbor Bankshares
BHB
$666M
| $146K | ﹤0.01% |
5,205
+2,948
| +131% | +$81.5K |
|
2767
Coursera
COUR
$1.54B
| $146K | ﹤0.01% |
4,613
+3,651
| +380% | +$137K |
|
2768
IES Holdings
IESC
$15.2B
| $146K | ﹤0.01% |
3,197
+1,847
| +137% | +$89.8K |
|
2769
Lindblad Expeditions
LIND
$2.22B
| $146K | ﹤0.01% |
10,019
+5,914
| +144% | +$83.1K |
|
2770
Alaunos Therapeutics
TCRT
$4.86M
| $146K | ﹤0.01% |
538
+283
| +111% | +$86.5K |
|
|
ESPR
2771
DELISTED
Esperion Therapeutics
ESPR
| $145K | ﹤0.01% |
12,026
-7,182
| -37% | -$105K |
|
2772
Funko
FNKO
$328M
| $145K | ﹤0.01% |
7,970
+3,875
| +95% | +$73.2K |
|
2773
Geron
GERN
$949M
| $144K | ﹤0.01% |
105,631
+47,215
| +81% | +$63K |
|
|
GTHX
2774
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $144K | ﹤0.01% |
10,741
+5,805
| +118% | +$94.6K |
|
|
SDC
2775
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $144K | ﹤0.01% |
27,076
+20,197
| +294% | +$125K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.